Advanced search
Publication Cover
Scandinavian Journal of Clinical and Laboratory Investigation Volume 62, 2002 - Issue 5
Submit an article Journal homepage
38
Views
62
CrossRef citations to date
0
Altmetric
Research Article

Serum matrix metalloproteinase-9 concentration in angiographically assessed coronary artery disease

A. Kalela Departments of Medical Biochemistry and Surgery, University of Tampere Medical School, Tampere, Finland; VTT Biotechnology, VTT, Finland; Laboratory of Atherosclerosis Genetics, Department of Clinical Chemistry, Centre for Laboratory Medicine, Tampere University Hospital, Tampere, Finland
,
T. A. Koivu Departments of Medical Biochemistry and Surgery, University of Tampere Medical School, Tampere, Finland; VTT Biotechnology, VTT, Finland; Laboratory of Atherosclerosis Genetics, Department of Clinical Chemistry, Centre for Laboratory Medicine, Tampere University Hospital, Tampere, Finland
,
T. Sisto Departments of Medical Biochemistry and Surgery, University of Tampere Medical School, Tampere, Finland; VTT Biotechnology, VTT, Finland; Laboratory of Atherosclerosis Genetics, Department of Clinical Chemistry, Centre for Laboratory Medicine, Tampere University Hospital, Tampere, Finland
,
J. Kanervisto Departments of Medical Biochemistry and Surgery, University of Tampere Medical School, Tampere, Finland; VTT Biotechnology, VTT, Finland; Laboratory of Atherosclerosis Genetics, Department of Clinical Chemistry, Centre for Laboratory Medicine, Tampere University Hospital, Tampere, Finland
,
M Höyhtyä Departments of Medical Biochemistry and Surgery, University of Tampere Medical School, Tampere, Finland; VTT Biotechnology, VTT, Finland; Laboratory of Atherosclerosis Genetics, Department of Clinical Chemistry, Centre for Laboratory Medicine, Tampere University Hospital, Tampere, Finland
,
P. Sillanaukee Departments of Medical Biochemistry and Surgery, University of Tampere Medical School, Tampere, Finland; VTT Biotechnology, VTT, Finland; Laboratory of Atherosclerosis Genetics, Department of Clinical Chemistry, Centre for Laboratory Medicine, Tampere University Hospital, Tampere, Finland
,
T. Lehtimäki Departments of Medical Biochemistry and Surgery, University of Tampere Medical School, Tampere, Finland; VTT Biotechnology, VTT, Finland; Laboratory of Atherosclerosis Genetics, Department of Clinical Chemistry, Centre for Laboratory Medicine, Tampere University Hospital, Tampere, Finland
&
S. T. Nikkari Departments of Medical Biochemistry and Surgery, University of Tampere Medical School, Tampere, Finland; VTT Biotechnology, VTT, Finland; Laboratory of Atherosclerosis Genetics, Department of Clinical Chemistry, Centre for Laboratory Medicine, Tampere University Hospital, Tampere, Finland
 show all
Pages 337-342 | Published online: 08 Jul 2009

Citations (62)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Gayathri Gopalan, Veena S Rao & Vijay V Kakkar. (2010) An overview of urinary proteomics applications in human diseases. International Journal of High Throughput Screening 1, pages 183-192.
Read now
Jochen Metzger, Peter B. Luppa, David M. Good & Harald Mischak. (2009) Adapting mass spectrometry-based platforms for clinical proteomics applications: The capillary electrophoresis coupled mass spectrometry paradigm. Critical Reviews in Clinical Laboratory Sciences 46:3, pages 129-152.
Read now
CV Rizos, EN Liberopoulos, DP Mikhailidis & MS Elisaf. (2008) Pleiotropic effects of thiazolidinediones. Expert Opinion on Pharmacotherapy 9:7, pages 1087-1108.
Read now
A. Kalela, V. Limnell, J. Aittoniemi, V. Virtanen, O. Jaakkola, T. Lehtimäki & S. T. Nikkari. (2006) Serum matrix metalloproteinase‐9 and venous bypass graft occlusion. Scandinavian Journal of Clinical and Laboratory Investigation 66:1, pages 7-14.
Read now
J. Renko, A. Kalela, O. Jaakkola, S. Laine, M. Höyhtyä, H. Alho & S. T. Nikkari. (2004) Serum matrix metalloproteinase‐9 is elevated in men with a history of myocardial infarction. Scandinavian Journal of Clinical and Laboratory Investigation 64:3, pages 255-262.
Read now

Articles from other publishers (57)

Megan Wilson, Abdullah Al‐Hamid, Ismail Abbas, Jason Birkett, Iftikhar Khan, Matthew Harper, Dhiya Al‐Jumeily OBE & Sulaf Assi. (2024) Identification of diagnostic biomarkers used in the diagnosis of cardiovascular diseases and diabetes mellitus: A systematic review of quantitative studies. Diabetes, Obesity and Metabolism.
Crossref
T. S. Panevin, M. S. Eliseev & E. L. Nasonov. (2021) Urate-lowering drugs in the treatment of gout: The unknown about the known. Rheumatology Science and Practice 59:6, pages 727-737.
Crossref
Marko Kumric, Josip A. Borovac, Dinko Martinovic, Tina Ticinovic Kurir & Josko Bozic. (2021) Circulating Biomarkers Reflecting Destabilization Mechanisms of Coronary Artery Plaques: Are We Looking for the Impossible?. Biomolecules 11:6, pages 881.
Crossref
Mustafa Umut Somuncu, Hamdi Pusuroglu, Huseyin Karakurt, İsmail Bolat, Seda Tukenmez Karakurt, Ali Riza Demir, Nilgun Isıksacan, Ozgur Akgul & Ozgur Surgit. (2020) The prognostic value of elevated matrix metalloproteinase-9 in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: A two-year prospective study. Revista Portuguesa de Cardiologia (English Edition) 39:5, pages 267-276.
Crossref
Mustafa Umut Somuncu, Hamdi Pusuroglu, Huseyin Karakurt, İsmail Bolat, Seda Tukenmez Karakurt, Ali Riza Demir, Nilgun Isıksacan, Ozgur Akgul & Ozgur Surgit. (2020) The prognostic value of elevated matrix metalloproteinase-9 in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: A two-year prospective study. Revista Portuguesa de Cardiologia 39:5, pages 267-276.
Crossref
Y. N. BelenkovE. V. PrivalovaA. O. IusupovaA. V. Zhito. (2019) Markers of Vascular Wall Fibrosis Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinases-1 in Patients with Ischemic Heart Disease with and without Concomitant Type-2 Diabetes Mellitus. Kardiologiia 59:5, pages 61-66.
Crossref
Seyed Reza Mirhafez, Amir Avan, Mohammad Tajfard, Shabnam Mohammadi, Mohsen Moohebati, Arash Fallah, Hamed Ghazavi, Hossein Savadi & Majid Ghayour Mobarhan. (2017) Relationship between serum cytokines receptors and matrix metalloproteinase 9 levels and coronary artery disease. Journal of Clinical Laboratory Analysis 31:5, pages e22100.
Crossref
Chongke ZhongJingyuan YangTan XuTian XuYanbo PengAili WangJinchao WangHao PengQunwei LiZhong JuDeqin GengYonghong ZhangJiang HeJiang He, Yonghong Zhang, Tan Xu, Dali Wang, Yanbo Peng, Jinchao Wang, Zhong Ju, Qunwei Li, Deqin Geng, Jintao Zhang, Dong Li, Fengshan Zhang, Libing Guo, Yingxian Sun, Xuemei Wang, Yong Cui, Yongqiu Li, Dihui Ma, Dongsheng Zhang, Guang Yang, Yanjun Gao, Liang Zhao, Xiaodong Yuan, Xiujie Han, Mingyu Zhang, Shurong Duan, Tao Feng, Jizhen Li, Suzhen Liu, Wei Hu, Chun Nie & Nuenjiya Zhao. (2017) Serum matrix metalloproteinase-9 levels and prognosis of acute ischemic stroke. Neurology 89:8, pages 805-812.
Crossref
Margaret Kurzius-Spencer, Robin B Harris, Vern Hartz, Jason Roberge, Chiu-Hsieh Hsu, Mary Kay O'Rourke & Jefferey L Burgess. (2015) Relation of dietary inorganic arsenic to serum matrix metalloproteinase-9 (MMP-9) at different threshold concentrations of tap water arsenic. Journal of Exposure Science & Environmental Epidemiology 26:5, pages 445-451.
Crossref
Mei Dong, Faxin Ren, Fengli Li, Chuanhuan Zhang, Jun Yang & Nan Mu. (2015) Matrix Metalloproteinase-9 in the Culprit Coronary Artery and Myocardial No-Reflow. The American Journal of the Medical Sciences 350:5, pages 352-356.
Crossref
S. Silva, E. Combet, M. E. Figueira, T. Koeck, W. Mullen & M. R. Bronze. (2015) New perspectives on bioactivity of olive oil: evidence from animal models, human interventions and the use of urinary proteomic biomarkers. Proceedings of the Nutrition Society 74:3, pages 268-281.
Crossref
Aline Azevedo, Alejandro F. Prado, Raquel C. Antonio, Joao P. Issa & Raquel F. Gerlach. (2014) Matrix Metalloproteinases are Involved in Cardiovascular Diseases. Basic & Clinical Pharmacology & Toxicology 115:4, pages 301-314.
Crossref
Zhibin Zhou, Xiaohao Li, Bo Yang & Dan Jiang. (2014) Relationship between lysophosphatidic acid and matrix metalloproteinase-9 plasma concentrations and carotid atheromatous plaque stability in patients with cerebral infarction. Journal of International Medical Research 42:3, pages 669-676.
Crossref
Eva Rodríguez-Suárez, Justyna Siwy, Petra Zürbig & Harald Mischak. (2014) Urine as a source for clinical proteome analysis: From discovery to clinical application. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 1844:5, pages 884-898.
Crossref
Hyun Soo Kim, Jong Shin Woo, Bu Yong Kim, Hyun Hee Jang, Seung Joon Hwang, Sung Jin Kwon, Eun Young Choi, Jin Bae Kim, Xianwu Cheng, Enze Jin, Woo Shik Kim, Kwon Sam Kim & Weon Kim. (2014) Biochemical and clinical correlation of intraplaque neovascularization using contrast-enhanced ultrasound of the carotid artery. Atherosclerosis 233:2, pages 579-583.
Crossref
Balraj Mittal, Avshesh Mishra, Anshika Srivastava, Surendra Kumar & Naveen Garg. 2014. 1 72 .
Andy Yong, Gabrielle Pennings, Clement Wong, Ashkan Javadzadegan, David Brieger, Harry Lowe, Miao Qi, Masud Behnia, Steven Krilis & Leonard Kritharides. (2013) Intracoronary upregulation of platelet extracellular matrix metalloproteinase inducer (CD147) in coronary disease. International Journal of Cardiology 166:3, pages 716-721.
Crossref
Jefferey L Burgess, Margaret Kurzius-Spencer, Mary Kay O'Rourke, Sally R Littau, Jason Roberge, Maria Mercedes Meza-Montenegro, Luis Enrique Gutiérrez-Millán & Robin B Harris. (2012) Environmental arsenic exposure and serum matrix metalloproteinase-9. Journal of Exposure Science & Environmental Epidemiology 23:2, pages 163-169.
Crossref
Savas GuzelOzden SerinEda Celik GuzelBanu BuyukG?zin Y?lmazGuvenc G?venen. (2013) Interleukin-33, matrix metalloproteinase-9, and tissue inhibitor of matrix metalloproteinase-1 in myocardial infarction. The Korean Journal of Internal Medicine 28:2, pages 165.
Crossref
Jie Wang, Xiaochen Yang, Fuyong Chu, Jianxin Chen, Qingyong He, Kuiwu Yao, Fei Teng, Yonghong Gao, Yanhui Xing, Aiming Wu & Yanwei Xing. (2013) The Effects of Xuefu Zhuyu and Shengmai on the Evolution of Syndromes and Inflammatory Markers in Patients with Unstable Angina Pectoris after Percutaneous Coronary Intervention: A Randomised Controlled Clinical Trial. Evidence-Based Complementary and Alternative Medicine 2013, pages 1-9.
Crossref
Derek L Mattey, Nicola B Nixon & Peter T Dawes. (2012) Association of circulating levels of MMP-8 with mortality from respiratory disease in patients with rheumatoid arthritis. Arthritis Research & Therapy 14:5, pages R204.
Crossref
Petra Zürbig, Hassan Dihazi, Jochen Metzger, Visith Thongboonkerd & Antonia Vlahou. (2011) Urine proteomics in kidney and urogenital diseases: Moving towards clinical applications. PROTEOMICS – Clinical Applications 5:5-6, pages 256-268.
Crossref
Ku-Chung Chen, Yung-Song Wang, Ching-Yu Hu, Wei-Chiao Chang, Yi-Chu Liao, Chia-Yen Dai & Suh-Hang Hank Juo. (2011) OxLDL up‐regulates microRNA‐29b, leading to epigenetic modifications of MMP‐2/MMP‐9 genes: a novel mechanism for cardiovascular diseases . The FASEB Journal 25:5, pages 1718-1728.
Crossref
Eric Schiffer, Sophie Liabeuf, Chrystelle Lacroix, Mohamed Temmar, Cedric Renard, Bernard Monsarrat, Gabriel Choukroun, Horst-Dieter Lemke, Raymond Vanholder, Harald Mischak & Ziad A Massy. (2011) Markers of vascular disease in plasma from patients with chronic kidney disease identified by proteomic analysis. Journal of Hypertension 29:4, pages 783-790.
Crossref
S. Demyanets, K. Huber & J. Wojta. (2011) Inflammation and the cardiovascular systemEntzündung und das Herzkreislaufsystem. European Surgery 43:2, pages 78-89.
Crossref
Gina Biasillo, Milena Leo, Roberta Della Bona & Luigi Marzio Biasucci. (2010) Inflammatory biomarkers and coronary heart disease: from bench to bedside and back. Internal and Emergency Medicine 5:3, pages 225-233.
Crossref
Magnus Bäck, Daniel F.J. Ketelhuth & Stefan Agewall. (2010) Matrix Metalloproteinases in Atherothrombosis. Progress in Cardiovascular Diseases 52:5, pages 410-428.
Crossref
Tommy Heryantho, Andi Wijaya & Teguh Santoso. (2009) Biochemical Markers for Determining Vulnerable Atherosclerotic Plaque in Stenotic Patient: Biochemical Markers Study of Myeloperoxidase (MPO), Matrix Metallo-Proteinase-9 (MMP-9), Secretory Phospholipase A2 (SPLA2) and CD40 Ligand. The Indonesian Biomedical Journal 1:2, pages 59.
Crossref
P‐Ö. Söder, J. H. Meurman, T. Jogestrand, J. Nowak & B. Söder. (2009) Matrix metalloproteinase‐9 and tissue inhibitor of matrix metalloproteinase‐1 in blood as markers for early atherosclerosis in subjects with chronic periodontitis. Journal of Periodontal Research 44:4, pages 452-458.
Crossref
N. P. E. Kadoglou, F. Iliadis, N. Angelopoulou, D. Perrea, C. D. Liapis & M. Alevizos. (2008) Beneficial effects of rosiglitazone on novel cardiovascular risk factors in patients with Type 2 diabetes mellitus. Diabetic Medicine 25:3, pages 333-340.
Crossref
Zhong-Xuan Ye, Hsin-Bang Leu, Tao-Cheng Wu, Shing-Jong Lin & Jaw-Wen Chen. (2008) Baseline serum matrix metalloproteinase-9 level predicts long-term prognosis after coronary revascularizations in stable coronary artery disease. Clinical Biochemistry 41:4-5, pages 292-298.
Crossref
Lukas U. Zimmerli, Eric Schiffer, Petra Zürbig, David M. Good, Markus Kellmann, Laetitia Mouls, Andrew R. Pitt, Joshua J. Coon, Roland E. Schmieder, Karlheinz H. Peter, Harald Mischak, Walter Kolch, Christian Delles & Anna F. Dominiczak. (2008) Urinary Proteomic Biomarkers in Coronary Artery Disease. Molecular & Cellular Proteomics 7:2, pages 290-298.
Crossref
Viorica Lopez-AvilaJuliet V. Spencer. (2017) Methods for Detection of Matrix Metalloproteinases as Biomarkers in Cardiovascular Disease. Clinical medicine. Cardiology 2, pages CMC.S484.
Crossref
Jozefa Dabek, Andrzej Kulach & Zbigniew Gasior. (2007) The role of matrix metalloproteinases in acute coronary syndromes. European Journal of Internal Medicine 18:6, pages 463-466.
Crossref
Yu Liu, Zuyi Yuan, Yan Liu, Jijun Zhang, Ping Yin, Dongqi Wang, Yanni Wang, Chiharu Kishimoto & Aiqun Ma. (2007) PPAR? gene C161T substitution is associated with reduced risk of coronary artery disease and decreased proinflammatory cytokine expression. American Heart Journal 154:4, pages 718-724.
Crossref
José A. Rodríguez, Josune Orbe & José A. Páramo. (2007) Metaloproteasas, remodelado vascular y syndromes aterotrombóticos. Revista Española de Cardiología 60:9, pages 959-967.
Crossref
Wannakorn Phatharajaree, Arintaya Phrommintikul & Nipon Chattipakorn. (2007) Matrix metalloproteinases and myocardial infarction. Canadian Journal of Cardiology 23:9, pages 727-733.
Crossref
Wei JIA, Qiang YUAN, Yong-ping LIANG, Hui-ming WANG, Xiang-qun HAN, Shu-qiao YIN, Xiao-mei ZHU & Gui-zhi LIU. (2007) Serum metrix metalloproteinase-9 combined with homocysteine, IL-6, TNF-α, CRP, HbA1c and lipid profile in the incipient diabetic nephropathy with or without macrovascular diseases. Journal of Medical Colleges of PLA 22:2, pages 111-114.
Crossref
Peter Libby & William Sasiela. (2006) Plaque Stabilization: Can We Turn Theory into Evidence?. The American Journal of Cardiology 98:11, pages S26-S33.
Crossref
Lennart Nilsson, Lena Jonasson, Johnny Nijm, Anders Hamsten & Per Eriksson. (2006) Increased Plasma Concentration of Matrix Metalloproteinase-7 in Patients with Coronary Artery Disease. Clinical Chemistry 52:8, pages 1522-1527.
Crossref
Florian Blaschke, Robert Spanheimer, Mehmood Khan & Ronald E. Law. (2006) Vascular effects of TZDs: New implications. Vascular Pharmacology 45:1, pages 3-18.
Crossref
Johan Sundström & Ramachandran S Vasan. (2006) Circulating biomarkers of extracellular matrix remodeling and risk of atherosclerotic events. Current Opinion in Lipidology 17:1, pages 45-53.
Crossref
Mike Sampson, Steven Wall, Mark Baugh, Jo Worley, Isabel Davies, David Hughes & Jelena Gavrilovic. (2006) Monocyte matrix and ADAM metalloproteinase expression in type 2 diabetes after aspirin therapy. Diabetes Research and Clinical Practice 71:1, pages 45-51.
Crossref
Tiina Solakivi, Olli Jaakkola, Anne Kalela, Mari Pispa, Anne Salomäki, Terho Lehtimäki, Matti Höyhtyä, Hannu Jokela & Seppo T Nikkari. (2005) Lipoprotein docosapentaenoic acid is associated with serum matrix metalloproteinase-9 concentration. Lipids in Health and Disease 4:1.
Crossref
John G. Hanly & Melanie J. Harrison. (2005) Management of neuropsychiatric lupus. Best Practice & Research Clinical Rheumatology 19:5, pages 799-821.
Crossref
T. C. Wu, H. B. Leu, W. T. Lin, C. P. Lin, S. J. Lin & J. W. Chen. (2005) Plasma matrix metalloproteinase‐3 level is an independent prognostic factor in stable coronary artery disease. European Journal of Clinical Investigation 35:9, pages 537-545.
Crossref
Eric T. ChoiEmily T. CollinsLeopoldo A. MarineMaria G. UbertiHisashi UchidaJeremy E. LeidenfrostM. Faisal KhanKenneth P. BocDana R. AbendscheinWilliam C. Parks. (2005) Matrix Metalloproteinase-9 Modulation by Resident Arterial Cells Is Responsible for Injury-Induced Accelerated Atherosclerotic Plaque Development in Apolipoprotein E–Deficient Mice. Arteriosclerosis, Thrombosis, and Vascular Biology 25:5, pages 1020-1025.
Crossref
John G. Hanly. (2005) Neuropsychiatric Lupus. Rheumatic Disease Clinics of North America 31:2, pages 273-298.
Crossref
YasminSharon WallaceCarmel M. McEnieryZahid DakhamPawan PusalkarKaisa Maki-PetajaMike J. AshbyJohn R. CockcroftIan B. Wilkinson. (2005) Matrix Metalloproteinase-9 (MMP-9), MMP-2, and Serum Elastase Activity Are Associated With Systolic Hypertension and Arterial Stiffness. Arteriosclerosis, Thrombosis, and Vascular Biology 25:2, pages 372-378.
Crossref
Shuichiro Higo, Masaaki Uematsu, Masakazu Yamagishi, Hatsue Ishibashi-Ueda, Masaki Awata, Takakazu Morozumi, Tomoki Ohara, Shinsuke Nanto & Seiki Nagata. (2005) Elevation of Plasma Matrix Metalloproteinase-9 in the Culprit Coronary Artery in Patients With Acute Myocardial Infarction Clinical Evidence From Distal Protection. Circulation Journal 69:10, pages 1180-1185.
Crossref
Ryuichi Kato, Yukihiko Momiyama, Reiko Ohmori, Hiroaki Taniguchi, Haruo Nakamura & Fumitaka Ohsuzu. (2005) Plasma Matrix Metalloproteinase-8 Concentrations are Associated With the Presence and Severity of Coronary Artery Disease. Circulation Journal 69:9, pages 1035-1040.
Crossref
M. H. TAYEBJEE, K. T. TAN, R. J. MACFADYEN & G. Y. H. LIP. (2004) Abnormal circulating levels of metalloprotease 9 and its tissue inhibitor 1 in angiographically proven peripheral arterial disease: relationship to disease severity. Journal of Internal Medicine 257:1, pages 110-116.
Crossref
J. Sundstrom. (2004) Relations of Plasma Matrix Metalloproteinase-9 to Clinical Cardiovascular Risk Factors and Echocardiographic Left Ventricular Measures: The Framingham Heart Study. Circulation 109:23, pages 2850-2856.
Crossref
Noboru Watanabe & Uichi Ikeda. (2004) Matrix metalloproteinases and atherosclerosis. Current Atherosclerosis Reports 6:2, pages 112-120.
Crossref
Hanna Ainiala, Aki Hietaharju, Prasun Dastidar, Jukka Loukkola, Terho Lehtimäki, Jukka Peltola, Markku Korpela, Tomi Heinonen & Seppo T. Nikkari. (2004) Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities. Arthritis & Rheumatism 50:3, pages 858-865.
Crossref
Marek H. Dominiczak. (2003) Deteriorating fuel metabolism, inflammation and coronary disease: are we closer to an all-encompassing theory?. Current Opinion in Lipidology 14:6, pages 639-642.
Crossref
H. Roger Lijnen. (2003) Metalloproteinases in Development and Progression of Vascular Disease. Pathophysiology of Haemostasis and Thrombosis 33:5-6, pages 275-281.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.